After Lykos' rejection from the FDA last year, companies trying to navigate the psychedelic drug trial sector face various ...

Lophora , a Danish biotech advancing next-generation psychedelic therapies, announced the first subjects have been dosed in its Phase 1 clinical tria ...

Curcumin, a phenolic antioxidant extracted from the rhizomes of turmeric and other Curcuma species, possesses strong ...

Serotonin syndrome is a preventable, drug-related complication that results from increased brain-stem serotonin activity, usually precipitated by the use of one or more serotonergic drugs. Its ...